Skip to main content

Wifiblast International has won a copyright infringement lawsuit against Wodaxun Technology

 


Wifiblast International is the maker of all original wifiblast wifi range extenders. Due to its success, copycats of the product started permeating online. In 2020 Wifiblast International won a copyright infringement suit against a chinese company, Wodaxun Technology in a $2M lawsuit for using the name wifiblast.

  • Wifiblast International has won a copyright infringement lawsuit against Wodaxun Technology. 
  • Wifiblast International filed a lawsuit against Wodaxun Technology in October 2020 over claims that the Chinese company used the company's brand name "Wifiblast" without permission.
  • Documents from Central District Court state that Wodaxun Technology and Wifiblast International reached a judgement in May 2021. Wodaxun Technology will pay Wifiblast International $2,00,000.
  • Wifiblast International's lawsuit states that between July 2018 and October 2020, Wodaxun Technology sold 1,230,000 units of wifi range extenders on Ebay and Amazon, under the brand name "wifiblast."
  • Wodaxun Technology's team denied Wifiblast International's request, but subponaed documents from both Ebay and Amazon shows Wodaxun Technology's and other chinese companies have used the company's brand name "Wifiblast" without permission for years. Click here for more


Labels:

Comments

Post a Comment

Popular posts from this blog

The Truth Behind Trump’s Tale of a Harrowing Helicopter Ride and Emergency Landing That Never Happened

The Truth Behind Trump’s Tale of a Harrowing Helicopter Ride and Emergency Landing That Never Happened. By Mary Jones and Ben Emos | Thursday, August  15 , 2024 | 6 min read During Donald Trump’s political campaigns, particularly in 2016 and 2020, he often  employed personal attacks and misinformation to undermine his opponents. In 2016, Trump targeted Hillary Clinton by focusing on her husband’s extramarital affairs, hoping to tarnish her public image. By 2020, his strategy shifted to Hunter Biden’s business ventures, with Trump attempting to discredit Joe Biden by associating him with his son’s dealings. In both cases, the goal was clear: damage the opponent’s reputation through a blend of accusations, half-truths, and outright falsehoods. In yet another one of his colorful anecdotes, former President Donald Trump claimed he experienced an emergency helicopter landing alongside former San Francisco Mayor Willie Brown. Trump described the situation as a tense moment, suggesti...
Post a Comment
Read more

Kamala Harris Is Far From An Enigma

Kamala Harris Is Far From An Enigma By Ben Emos and Tony Bruce | Wednesday, September  25 , 2024 | 7 min read Recently, critics have argued that Vice President Kamala Harris hasn’t fully fleshed out her policies, raising concerns about the clarity of her agenda. Interestingly, this critique mirrors rhetoric often used by former President Donald Trump, who is known for diverting attention from more controversial issues. In this case, it could be seen as a way to shift the spotlight away from growing unease around the GOP’s Project 2025 and the more symbolic “eating of cats and dogs” controversy in Springfield, Ohio. Project 2025, the Republican-backed policy framework, has stirred concern due to its extreme deregulation measures and rollbacks on protections for vulnerable communities. Critics of the plan argue that it represents a significant threat to public health, environmental safety, and economic equality. The “eating of cats and dogs” metaphor, while not literal, encapsulates ...
Post a Comment
Read more

Eroxon Gel Authorized by FDA to Treat Erectile Dysfunction. What to Know

Eroxon Gel Authorized by FDA to Treat Erectile Dysfunction. What to Know By Mary Jones | Monday, July  1 , 2024 | 3 min read The FDA has allowed a new topical gel Eroxon to be sold over the counter to help treat erectile dysfunction. The approval was for marketing Eroxon as an over-the-counter option, the first in the United States. Eroxon is already available in parts of the United Kingdom and Europe, though a release timeline in the U.S. is unclear. MED3000, a new gel sold as Eroxon, has been approved for marketing by the  Food and Drug Ad ministration  (FDA)  to treat erectile dysfunction. Eroxon received a “de novo” classification by the FDA, which means it can be marketed as an  over-the-counter (OTC) option  for those with erectile dysfunction, a first in the market. According to the  National Institutes of Health (NIH)Trusted Source , around 30 million Americans have erectile dysfunction. TREATMENT GEL FOR ERECTILE DYSFUNCTION Dr. Amy Pearlman ,...
Post a Comment
Read more